Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -4.00 (-1.22%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director dealing & appointment

29 May 2012 16:54

RNS Number : 3543E
BrainJuicer Group PLC
29 May 2012
 



 

 

 

 

Press Release

 29 May 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Director Appointment and Director Dealing

 

BrainJuicer (AIM: BJU), a leading international online market research agency, announced on 23rd April 2012 that Simon Godfrey, a non-executive director of the Company, intends to retire from the board of directors by the end of September 2012.

 

He has been reducing his shareholding as a result, and the Company updates that Simon has today disposed of 10,000 shares at 308.50p per share. Following the above transaction, Simon currently holds 14,298 shares representing 0.1% of the voting rights of the Company.

 

As a replacement for Simon, the Board is appointing Graham Blashill (aged 65) as a non-executive director with effect from 1st July 2012. Graham has had a long career in sales and marketing of fast moving consumer goods. He joined W.D.& H.O. Wills (a division of Imperial Tobacco) in 1968, holding a number of marketing and trading roles, and becoming Managing Director Imperial Tobacco UK in 1995. In 2003 he was Regional Director for Western Europe, and in 2005 appointed Group Sales and Marketing Director responsible for Imperial Tobacco's global trading operations in over 160 countries. He served as a main board director of Imperial Tobacco Group plc, a leading FTSE 100 company, for six years before retiring in 2011.

 

Disclosures regarding Mr Blashill appointment, pursuant to AIM rules (Schedule 2 paragraph (g)), are set out below:

 

Directorships held within the last five years

 

·; Imperial Tobacco Group Plc

·; Imperial Tobacco Limited

·; Imperial Tobacco Overseas Holdings (3) Limited

·; Imperial Tobacco International Limited

·; Altadis S.A.U.

·; Skruf Snus AB

·; Societe Nationale D'explotation Industrielle Des Tabacs et Allumettes SAS (SEITA)

·; Imperial Tobacco Pension Trustees Limited

·; Tobacco Trade Benevolent Association

 

Current Directorships

 

·; Tobacco Pipe Makers and Tobacco Trade Benevolent Fund

 

There is no further information to be disclosed under AIM rules (Schedule 2 paragraph (g)) in respect of Mr Blashill's appointment.

 

The Company can be found at www.brainjuicer.com.

 

- Ends -

 

For further information, please contact:

BrainJuicer Group PLC

 

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

 

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZKKLFGZZM
Date   Source Headline
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.